Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Government agencies communicate via .gov.sg websites (e.g. go.gov.sg/open). Trusted websites
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary
U

Ursodeoxycholic Acid

Availability of ACE Drug Guidance

Yes

Biologics Drug Information Overview

No

Subsidy Information and Financing Scheme

Standard Drug List

Active ingredient: Ursodeoxycholic Acid

General information

Subsidy Information and Financing Scheme

[SDL] Ursodeoxycholic Acid Capsule 250 mg

[SDL] Ursodeoxycholic Acid Suspension 50 mg/mL

[SDL] Ursodeoxycholic Acid Tablet 500 mg

View legend

Drug Guidance for Subsidy

01/09/2020 Ursodeoxycholic acid for treating primary biliary cirrhosis

The Ministry of Health’s Drug Advisory Committee has recommended:

  • Ursodeoxycholic acid 250 mg capsule, 500 mg tablet and 50 mg/ml suspension for treating primary biliary cirrhosis in patients without decompensated hepatic cirrhosis.

Subsidy status

[R] Ursodeoxycholic acid 250 mg capsule, 500 mg tablet and 50 mg/ml suspension are recommended for inclusion on the MOH Standard Drug List (SDL).

[R] Ursodeoxycholic acid 50 mg/ml suspension does not have regulatory approval with the Health Sciences Authority (HSA). The responsibility of prescribing an unregistered product to patients lies with the treating clinician. Before treatment is started, it is important to consider the availability of other suitable registered alternatives and inform the patient or their carer that the product is unregistered.

View legend

General Availability in Public Healthcare Institution

Note:

General availability information reflected is based on the Public Healthcare Institutions’ (PHI) formulary on what is commonly used for treating their patient population and may or may not be available for patients not under the care of that institution. It does not reflect the PHI’s actual inventory availability and is subjected to change. Please consult the Public Hospitals or Polyclinics for details on availability and supply restrictions/considerations. General availability is not tied to any brand unless otherwise stated.

Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration

Availability information

Formulation

Public Healthcare Institution

Capsule 250 mg

  1. Alexandra Hospital

  2. Changi General Hospital

  3. KK Women's and Children's Hospital

  4. Khoo Teck Puat Hospital

  5. National Cancer Centre

  6. Ng Teng Fong General Hospital

  7. National University Hospital

  8. Sengkang General Hospital

  9. Singapore General Hospital

  10. Tan Tock Seng Hospital

  11. Woodlands Health Campus

Suspension 50 mg/mL

  1. KK Women's and Children's Hospital

  2. National University Hospital

Registered Product(s) Information

Clinical and product info

Clinical info

Product Info

Information under the Indication, Dosage and Contraindication sections are extracted from the relevant Package Insert/Patient Information Leaflet of the product available on HSA Infosearch. For more information, please refer to the product's Package Insert/ Patient Information Leaflet available on HSA Infosearch.

The information provided is for informational purposes only, and is not exhaustive. The information provided is not a substitute for professional medical advice. Please consult a qualified healthcare provider for any medical advice.

Information available here are product details as registered with the HSA. As this website is updated monthly, please refer to HSA Infosearch for the most updated product information.

Oral

* Clinical information is available for this product.

Back to top